Smart-Responsive Nucleic Acid Nanoparticles (NANPs) with the Potential to Modulate Immune Behavior

Area of Science:

• Nanotechnology
• Biomaterials Science
• Immunology

Background:

• Nucleic acids offer programmable, biocompatible platforms for nanotechnology.
• Immunostimulatory properties and structural stagnation of nucleic acid materials hinder therapeutic applications.
• Dynamic structural design is needed to unlock the full potential of nucleic acid-based nanomedicines.

Purpose of the Study:

• To address challenges in nucleic acid-based nanotechnology by developing dynamic nanoparticles.
• To establish structure-property relationships between nanoparticle design and immunomodulatory effects.
• To explore advanced design principles for fine-tuning nanoparticle function in biosensing and therapeutics.

Main Methods:

• Assembly of three-dimensional, planar, and fibrous nucleic acid-based nanoparticles (NANPs).
• Analysis of NANP immunomodulatory properties in human peripheral blood mononuclear cells (PBMCs).
• Correlation of programmable architectural and physicochemical parameters with observed immune responses.

Main Results:

• Established links between NANP design parameters and their immunomodulatory effects.
• Demonstrated the conditional activation of embedded functions within NANPs.
• Identified key factors influencing the interaction of NANPs with immune cells.

Conclusions:

• Dynamic NANPs offer a strategy to overcome limitations in nucleic acid-based nanotechnology.
• Fine-tuning NANP design allows for control over both physicochemical and immunostimulatory properties.
• These advancements hold significant potential for novel biosensing and therapeutic applications.